Investor · Seattle, WA

Mark Frohlich

Open Mark in the network graph →

Filings

3

SEC Form D

Connections

34

co-filers

Capital

$934.2M

across filings

Active

Jul 2015

to Oct 2025

Most-connected co-filers (34)

Lori Hu · New York, NY2 shared Ronald Martell · West Lafayette, IN2 shared Fabio Pucci · San Diego, CA2 shared Ronald Martell · Houston, TX2 shared Marc J. Tessier-Lavigne · Seattle, WA1 shared Hyam Levitsky · Seattle, WA1 shared Howard J. Pien · Seattle, WA1 shared Hans Bishop · Seattle, WA1 shared Mary A. Wilderotter · Seattle, WA1 shared Bernard J. Cassidy · Seattle, WA1 shared Patricio A. Stocker · Toronto, Ontario, Canada1 shared Gordon A. Gardiner · KIRKLAND, WA1 shared Scott A. Laitinen · Toronto, Ontario, Canada1 shared Paul A. Wyckoff · KIRKLAND, WA1 shared Chris A. Mccormack · KIRKLAND, WA1 shared Carlos Manuel A. Uribe · Toronto, Ontario, Canada1 shared Ernest T. Cummins · Albuquerque, NM1 shared Steven D. Mckean · KIRKLAND, WA1 shared Christopher A. Hansen · Toronto, Ontario, Canada1 shared Stephan A. Weitz · KIRKLAND, WA1 shared Julie A. Barbo · KIRKLAND, WA1 shared Paul M. Duncan · Arvada, CO1 shared Robin Dyche · Albuquerque, NM1 shared Simon A. Langelier · Toronto, Ontario, Canada1 shared

Recent filings (3)

Indapta Therapeutics Inc.Oct 2025 · 7 co-filers$51.6M Indapta Therapeutics Inc.Oct 2025 · 7 co-filers$51.6M Indapta Therapeutics Inc.Feb 2022 · 11 co-filers$67.1M Indapta Therapeutics Inc.Feb 2022 · 11 co-filers$67.1M Juno Therapeutics, Inc.Jul 2015 · 28 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mark in the interactive graph →